Schaefer K - Search Results

1

Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference.

Yang M, Morin CM, Schaefer K, Wallenstein GV. Yang M, et al. Among authors: schaefer k. Curr Med Res Opin. 2009 Oct;25(10):2487-94. doi: 10.1185/03007990903167415. Curr Med Res Opin. 2009. PMID: 19689221 Clinical Trial.

2

Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.

Snedecor SJ, Botteman MF, Bojke C, Schaefer K, Barry N, Pickard AS. Snedecor SJ, et al. Among authors: schaefer k. Sleep. 2009 Jun;32(6):817-24. doi: 10.1093/sleep/32.6.817. Sleep. 2009. PMID: 19544759 Free PMC article.

3

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.

Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK. Erman MK, et al. Among authors: schaefer k. J Clin Sleep Med. 2008 Jun 15;4(3):229-34. J Clin Sleep Med. 2008. PMID: 18595435 Free PMC article. Clinical Trial.

4

A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.

Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC. Fava M, et al. Among authors: schaefer k. J Clin Psychiatry. 2011 Apr;72(4):473-9. doi: 10.4088/JCP.09m05131gry. Epub 2010 Nov 2. J Clin Psychiatry. 2011. PMID: 21208574 Clinical Trial.

5

Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.

Snedecor SJ, Botteman MF, Schaefer K, Sarocco P, Barry N, Pickard AS. Snedecor SJ, et al. Among authors: schaefer k. J Ment Health Policy Econ. 2010 Mar;13(1):27-35. J Ment Health Policy Econ. 2010. PMID: 20571180 Clinical Trial.

6

A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.

Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T. Ancoli-Israel S, et al. Among authors: schaefer k. Sleep. 2010 Feb;33(2):225-34. doi: 10.1093/sleep/33.2.225. Sleep. 2010. PMID: 20175406 Free PMC article. Clinical Trial.

7

Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.

Botteman MF, Ozminkowski RJ, Wang S, Pashos CL, Schaefer K, Foley DJ. Botteman MF, et al. Among authors: schaefer k. CNS Drugs. 2007;21(4):319-34. doi: 10.2165/00023210-200721040-00005. CNS Drugs. 2007. PMID: 17381185 Clinical Trial.

8

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T. Walsh JK, et al. Among authors: schaefer k. Sleep. 2007 Aug;30(8):959-68. doi: 10.1093/sleep/30.8.959. Sleep. 2007. PMID: 17702264 Free PMC article. Clinical Trial.

9

Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.

Donohue JF, Parsey MV, Andrews C, D'Urzo T, Sharma S, Schaefer K, Claus R, Baumgartner RA; Levalbuterol COPD Study Group. Donohue JF, et al. Among authors: schaefer k. COPD. 2006 Aug;3(3):125-32. doi: 10.1080/15412550600829190. COPD. 2006. PMID: 17240614 Clinical Trial.

10

Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.

Pleskow WW, Nelson HS, Schaefer K, Claus R, Roach JM. Pleskow WW, et al. Among authors: schaefer k. Allergy Asthma Proc. 2004 Nov-Dec;25(6):429-36. Allergy Asthma Proc. 2004. PMID: 15709454 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results